This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

marketwatch.com/story/this-one-and-done-heart-disease-treatment-just-got-a-1-3-billion-endorsement-from-eli-lilly-5c163b61

Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.

This story appeared on marketwatch.com, 2025-06-17 12:13:00.
The Entire Business World on a Single Page. Free to Use →